石菖蒲Acori Tatarinowii Rhizoma为临床常用的芳香开窍药，在《神农本草经》中列为上品，炮制方法有净制、切制、药汁制等，目前主流的炮制方法为生用和麸炒，其化学成分包括苯丙素类、萜类、木脂素类及其他类。现代研究表明，石菖蒲具有镇静、抗惊厥、抗抑郁、抗癫痫、引药入脑等作用。通过对古代本草、医籍、《中国药典》、地方中药饮片炮制规范等进行整理，从石菖蒲的性能、功效、炮制历史沿革、化学成分等进行综述，同时对其现代炮制工艺、药理研究及临床应用等展开论述，为进一步探究石菖蒲及其炮制品的物质基础及炮制机制等相关研究提供参考。

Shichangpu (Acori Tatarinowii Rhizoma) is a clinically commonly used aromatic orifice-opening medicinal herb, classified as a superior-grade drug in the Shennong’s Classic of Materia Medica. Its processing methods include purification, cutting, and medicinal juice processing, etc., with the current mainstream techniques being raw use and bran stir-frying. The chemical constituents of Acori Tatarinowii Rhizoma primarily include phenylpropanoids, terpenoids, lignans, and other compounds. Modern research indicates that it exhibits sedative, anticonvulsant, antidepressant, antiepileptic, brain-targeting, and other effects. By reviewing ancient herbal medicine, medical books, Chinese Pharmacopoeia and local standards for the processing of traditional Chinese medicinal slices, this paper summarizes the properties, therapeutic effects, historical evolution of processing methods, and chemical constituents of Acori Tatarinowii Rhizoma. Additionally, it discusses modern processing techniques, pharmacological research, and clinical applications, providing a reference for further exploration of the material basis, processing mechanisms, and related studies of Acori Tatarinowii Rhizoma and its processed products.

R285

国家中医药管理局中药炮制技术传承创新项目（GZY-KJS-2022-051）；江西省中医药标委会标准化项目（2025A15）；江西省高水平本科教学团队《中成药学本科教学团队》（2252201013）；江西中医药大学虚拟教研室（2252300109）；首批科技创新团队（CXTD22003）；江西省教育厅科学技术研究项目（GJJ218920）；南昌医学院校级科研项目（NYXJ-2024-061）